Outcome of Board Meeting dated 28th May,2026
URAVIDEF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board approved audited standalone and consolidated financial results for Q4 and FY 2025-26. Standalone revenue declined to Rs 4,049.20 Lakhs from Rs 4,223.97 Lakhs (FY25), while standalone PAT fell to Rs 131.70 Lakhs from Rs 178.58 Lakhs. The company completed disposal of its 50.01% stake in SKL India (Private) Limited in Q4, receiving Rs 1,125.20 Lakhs. Additionally, 11,00,000 share warrants lapsed and were credited to retained earnings (Rs 907.50 Lakhs). Spafax International Holding Ltd was recognized as an associate after the company's holding crossed 20%. Auditors issued an un-modified opinion on standalone results but a modified opinion on consolidated results.
Revenue and profit declined year-on-year on standalone basis. The modified audit opinion on consolidated results signals potential concerns about subsidiary/accounting matters. Cash position weakened significantly with standalone cash dropping from Rs 258.99 Lakhs to Rs 66.26 Lakhs. The disposal of SKL India and warrant lapses affected financials.